AbbVie (ABBV) News Today $175.54 -1.03 (-0.58%) (As of 01:03 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Beyond Market Price: Uncovering AbbVie Inc's Intrinsic ValueDecember 10 at 8:20 AM | gurufocus.comAbbVie’s Phase III trial of Parkinson’s disease treatment meets primary endpointDecember 10 at 8:13 AM | finance.yahoo.comColdstream Capital Management Inc. Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)Coldstream Capital Management Inc. lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 5.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 62,071 shares of the company's stock afDecember 10 at 8:13 AM | marketbeat.comAbbVie's (ABBV) Neutral Rating Reiterated at Bank of AmericaBank of America reissued a "neutral" rating and issued a $191.00 price target on shares of AbbVie in a research note on Tuesday.December 10 at 8:08 AM | marketbeat.comGeode Capital Management LLC Lowers Stake in AbbVie Inc. (NYSE:ABBV)Geode Capital Management LLC cut its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 1.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 36,161,045 shares of the company's stock aDecember 10 at 7:23 AM | marketbeat.comAbbVie (NYSE:ABBV) Trading 0.8% Higher - Here's WhyAbbVie (NYSE:ABBV) Trading 0.8% Higher - Here's What HappenedDecember 9 at 3:29 PM | marketbeat.comTwo Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses As Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell LymphomaDecember 9 at 12:00 PM | prnewswire.comAbbVie's Early Parkinson's Candidate Hits Primary Goal In Pivotal Late-Stage StudyDecember 9 at 11:39 AM | benzinga.comAbbVie's third successful Parkinson's trial sets the stage for an eventful 2025December 9 at 11:01 AM | marketwatch.comAbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025December 9 at 10:54 AM | marketwatch.comAbbVie's Parkinson's disease drug meets main goal in late-stage studyDecember 9 at 8:10 AM | reuters.comLRI Investments LLC Acquires 4,723 Shares of AbbVie Inc. (NYSE:ABBV)LRI Investments LLC lifted its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 51.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,975 shares of the company's stock after buying an additional 4,723 sharesDecember 9 at 8:07 AM | marketbeat.comAbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's DiseaseDecember 9 at 8:00 AM | prnewswire.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Public Employees Retirement System of OhioPublic Employees Retirement System of Ohio decreased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 0.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 815,840 shares of the company's stock after selling 7,777 sharesDecember 9 at 7:18 AM | marketbeat.comNomura Asset Management Co. Ltd. Has $213.82 Million Stake in AbbVie Inc. (NYSE:ABBV)Nomura Asset Management Co. Ltd. lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 10.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,082,758 shares of the company's stock after purchasing an additional 103,590 shares duringDecember 9 at 6:36 AM | marketbeat.comAbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer PatientsDecember 8 at 3:00 PM | prnewswire.comMML Investors Services LLC Buys 11,580 Shares of AbbVie Inc. (NYSE:ABBV)MML Investors Services LLC lifted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 548,661 shares of the company's stock after acquiring an additiDecember 8 at 7:51 AM | marketbeat.comAbbVie announces updated results from Phase 1b/2 EPCORE NHL-2 trialDecember 8 at 7:16 AM | tipranks.comiA Global Asset Management Inc. Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV)iA Global Asset Management Inc. lessened its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 75.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 22,730 shares of the company's stock after selling 68,400 shares duDecember 8 at 5:42 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Wellington Management Group LLPWellington Management Group LLP reduced its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 45.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,567,155 shares of the company's stock after sellinDecember 8 at 5:21 AM | marketbeat.comAbbVie (NYSE:ABBV) Rating Lowered to Neutral at Daiwa Capital MarketsDecember 8 at 2:52 AM | americanbankingnews.comAbbVie (NYSE:ABBV) Cut to "Hold" at Daiwa AmericaDecember 8 at 1:43 AM | americanbankingnews.comAbbVie: Epcoritamab Combo Shows High Response Rates In R/R Follicular Lymphoma TrialDecember 8 at 12:06 AM | markets.businessinsider.comDecember 7 at 8:26 PM | gurufocus.comAbbVie Inc (ABBV) Reports Promising Results for Epcoritamab in Follicular Lymphoma TrialDecember 7 at 8:26 PM | gurufocus.comInvestigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)December 7 at 7:00 PM | prnewswire.comAbbVie Inc. (NYSE:ABBV) Holdings Lifted by Zacks Investment ManagementZacks Investment Management increased its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 11.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 853,207 shares of the company's stock afterDecember 7 at 8:35 AM | marketbeat.comZega Financial LLC Reduces Position in AbbVie Inc. (NYSE:ABBV)Zega Financial LLC lowered its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 66.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,470 shares of the company's stock after selling 2,904 shares duringDecember 7 at 8:35 AM | marketbeat.comZurich Insurance Group Ltd FI Sells 115,774 Shares of AbbVie Inc. (NYSE:ABBV)Zurich Insurance Group Ltd FI trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 23.5% in the third quarter, according to its most recent filing with the SEC. The firm owned 376,336 shares of the company's stock after selling 115,774 shares during the period. Zurich InsurancDecember 7 at 8:07 AM | marketbeat.comNational Bank of Canada FI Grows Holdings in AbbVie Inc. (NYSE:ABBV)National Bank of Canada FI raised its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 6.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,244,546 shares of the company's stock after acquiring an additionaDecember 7 at 7:56 AM | marketbeat.comEP Wealth Advisors LLC Purchases 9,298 Shares of AbbVie Inc. (NYSE:ABBV)EP Wealth Advisors LLC raised its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 10.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 100,347 shares of the company's stock after purchasing an addDecember 7 at 7:24 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) is United Services Automobile Association's 6th Largest PositionUnited Services Automobile Association trimmed its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 26.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 449,905 shares of the company's stock after selling 16December 7 at 7:12 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Stock Holdings Boosted by Kovitz Investment Group Partners LLCKovitz Investment Group Partners LLC raised its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 196.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 68,358 shares of the company's stock after purchasing anDecember 7 at 6:52 AM | marketbeat.comAbbVie (NYSE:ABBV) Stock Price Down 0.3% - Here's What HappenedAbbVie (NYSE:ABBV) Trading Down 0.3% - Here's WhyDecember 6, 2024 | marketbeat.comWorldquant Millennium Advisors LLC Grows Stake in AbbVie Inc. (NYSE:ABBV)Worldquant Millennium Advisors LLC grew its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 152.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 578,116 shares of the company's stock after purchaDecember 6, 2024 | marketbeat.comTemasek Holdings Private Ltd Has $46.11 Million Holdings in AbbVie Inc. (NYSE:ABBV)Temasek Holdings Private Ltd grew its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 21.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 233,498 shares of the company's stockDecember 6, 2024 | marketbeat.comTexas Capital Bank Wealth Management Services Inc Has $1.28 Million Position in AbbVie Inc. (NYSE:ABBV)Texas Capital Bank Wealth Management Services Inc boosted its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 109.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,493 shares of the company's stock after buying an additional 3,39December 6, 2024 | marketbeat.comAbbVie (NYSE:ABBV) Lowered to Hold Rating by Daiwa AmericaDaiwa America downgraded AbbVie from a "strong-buy" rating to a "hold" rating in a report on Thursday.December 6, 2024 | marketbeat.comAbbVie: Resilient Market Position and Growth Potential Justify Buy RatingDecember 5, 2024 | markets.businessinsider.comAbbVie (NYSE:ABBV) Shares Down 0.3% - Here's WhyAbbVie (NYSE:ABBV) Stock Price Down 0.3% - What's Next?December 5, 2024 | marketbeat.comHow To Put $100 In Your Retirement Fund Each Month With AbbVie StockDecember 5, 2024 | finance.yahoo.comAbbVie (NYSE:ABBV) Cut to "Neutral" at Daiwa Capital MarketsDaiwa Capital Markets downgraded shares of AbbVie from an "outperform" rating to a "neutral" rating and set a $180.00 target price for the company. in a research report on Thursday.December 5, 2024 | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Bought by State Street CorpState Street Corp lifted its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 1.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,067,935 shares of the company's stock after acquiring an additiDecember 5, 2024 | marketbeat.comStifel Financial Corp Sells 28,036 Shares of AbbVie Inc. (NYSE:ABBV)Stifel Financial Corp reduced its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 1.1% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,501,666 shares of the company's stock after selling 28,036 shares during the period. Stifel Financial Corp ownDecember 5, 2024 | marketbeat.comSageView Advisory Group LLC Cuts Stake in AbbVie Inc. (NYSE:ABBV)SageView Advisory Group LLC lowered its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 31.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,603 shares of the company's stocDecember 5, 2024 | marketbeat.comQuantinno Capital Management LP Acquires 54,769 Shares of AbbVie Inc. (NYSE:ABBV)Quantinno Capital Management LP raised its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 53.3% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 157,560 shares of the company's stock after acquiring an additional 54,769December 5, 2024 | marketbeat.comRoyal London Asset Management Ltd. Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV)Royal London Asset Management Ltd. lifted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 0.9% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,371,288 shares of the company's stock after buying an addiDecember 5, 2024 | marketbeat.comCheck Out What Whales Are Doing With ABBVDecember 5, 2024 | benzinga.comAbbVie downgraded to Neutral from Outperform at DaiwaDecember 4, 2024 | tipranks.comAbbVie (NYSE:ABBV) Shares Down 2.1% - Time to Sell?AbbVie (NYSE:ABBV) Trading Down 2.1% - Time to Sell?December 4, 2024 | marketbeat.com Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address With the “Bitcoin Loophole” you can help supercharge the gains by 10x or more! (Ad)You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet! >> Tap here to sign up and join them for the imminent workshop ABBV Media Mentions By Week ABBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼0.900.67▲Average Medical News Sentiment ABBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼5630▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News Today JNJ News Today MRK News Today PFE News Today BMY News Today ZTS News Today RPRX News Today JAZZ News Today CORT News Today PRGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 12/10/2024 by MarketBeat.com Staff From Our PartnersCoins Set to Soar with a Pro-Crypto White HouseCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump Won, But Can He Save Your 401(k)?Trump Won, But Your Savings Are Still In Danger It's the ONLY playbook that shows you how to fortify your f...Priority Gold | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
